| 标题 |
Abstract GS1-01: Her2climb-05: a randomized, double-blind, phase 3 study of tucatinib versus placebo in combination with trastuzumab and pertuzumab as maintenance therapy for her2+ metastatic breast cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:E. Hamilton; G. Curigliano; M. Martin; F. Lerebours; J. Tsurutani; et al 出版日期:2026-02-17 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)